Endo To Launch Opana ER Oxymorphone With Two Risk Management Programs

The firm will add 220 sales reps to support the July launch of the extended-release and immediate-release opioid analgesics.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet